enow.com Web Search

  1. Ads

    related to: long acting insulin pen names
    • Why Use New Needle

      Check the Tips To Help You Stay

      Prepared With a New Needle.

    • Contact Us

      Call Us For Your Queries.

      We Would Love To Help You.

Search results

  1. Results from the WOW.Com Content Network
  2. Insulin glargine - Wikipedia

    en.wikipedia.org/wiki/Insulin_glargine

    Insulin glargine sold under the brand name Lantus among others is a long-acting modified form of medical insulin, used in the management of type 1 and type 2 diabetes. [7] It is injected just under the skin . [ 7 ]

  3. Insulin (medication) - Wikipedia

    en.wikipedia.org/wiki/Insulin_(medication)

    The long acting insulin is given once (usually glargine, Lantus) or twice (usually detemir, Levemir) daily to provide a base, or basal insulin level. Rapid acting (RA) insulin is given before meals and snacks. A similar profile can be provided using an insulin pump where rapid acting insulin is given as the basal and premeal bolus insulin.

  4. Insulin degludec - Wikipedia

    en.wikipedia.org/wiki/Insulin_degludec

    Insulin degludec is an ultra-long acting insulin that, unlike insulin glargine, is active at a physiologic pH.The addition of hexadecanedioic acid via an amide linkage to lysine at the B29 position allows for the formation of multi-hexamers in subcutaneous tissues. [16]

  5. Novo Nordisk to discontinue Levemir insulin in U.S. market - AOL

    www.aol.com/news/novo-nordisk-discontinue...

    Novo has another long-acting insulin, Tresiba, on the market. "Novo Nordisk will phase out, then permanently discontinue Levemir in the U.S. on December 31, 2024," the company said in a statement.

  6. Insulin icodec - Wikipedia

    en.wikipedia.org/wiki/Insulin_icodec

    Insulin icodec, sold under the brand name Awiqli, is a medication used for the treatment of diabetes to improve glycemic control. [3] It is an ultralong-acting basal insulin analogue that is developed by Novo Nordisk .

  7. Insulin analog - Wikipedia

    en.wikipedia.org/wiki/Insulin_analog

    This is an ultralong-acting insulin analogue developed by Novo Nordisk, which markets it under the brand name Tresiba. It is administered once daily and has a duration of action that lasts up to 40 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir). [5] [6]

  1. Ads

    related to: long acting insulin pen names